ABOUT

NOFAAA was early-stage: real science, no published validation, and a funding round to raise. In biotech, credibility usually comes from data, and the data wasn't there yet. I built a brand system that had to carry that weight instead, working across investor presentations, clinical materials, and research contexts without changing register. The identity supported the company's first funding round.

CLIENT ▸ NOFAAA Therapeutics, NJ, USA
YEAR ▸ 2024
AREA ▸ Biotech — Precision Medicine (pre-validation)
AUDIENCE ▸ Investor, Clinical Collaborator, Scientific Community
AREA ▸ Therapeutics — Precision Medicine (pre-funding biotech)
AUDIENCE ▸ Investor, Strategic Partner, Scientific Community
SCOPE ▸ Brand system refresh, identity and rollout guidelines
ROLE ▸ Brand Design Lead (Freelance)
PROCESS ▸Brand audit → stakeholder workshop → visual identity → rollout